Le Mont sur Lausanne, Switzerland

Stephanie Michlig Gonzales

This inventor holds 1 USPTO granted patent. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Michlig Gonzales. Retrieved from https://idiyas.com/inventor/stephanie-michlig-gonzales

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stephanie Michlig Gonzales

Introduction

Stephanie Michlig Gonzales, a notable inventor based in Le Mont-sur-Lausanne, Switzerland, has made significant strides in the field of neurology. With a focus on enhancing treatment options for patients suffering from brain trauma and strokes, her innovative approach integrates natural compounds into therapeutic applications.

Latest Patents

Gonzales holds one patent, which is titled "Treatment or prevention of non-inflammatory neuronal damage from brain trauma and strokes using Menthol, Linalool and/or Icilin." This invention is particularly groundbreaking as it introduces compositions aimed at preventing or treating non-inflammatory neuronal damage, utilizing compounds such as Menthol, Linalool, and Icilin. These compositions are designed to be administered therapeutically, providing new hope for effective treatment strategies for individuals affected by such neurological conditions.

Career Highlights

Currently, Stephanie Michlig Gonzales is affiliated with Nestlé S.A., a leading global food and beverage company known for its dedication to research and innovation. Throughout her career, she has demonstrated a strong commitment to advancing the understanding and treatment of neuronal damage.

Collaborations

Working alongside accomplished colleagues, including Susana Camacho and Johannes Le Coutre, Gonzales has fostered collaborative efforts aimed at enhancing the efficacy of neurological treatments. Their combined expertise has facilitated a deeper exploration of how natural compounds can be leveraged in medical applications.

Conclusion

Stephanie Michlig Gonzales exemplifies the spirit of innovation within the field of neurotherapeutics. Her pioneering patent not only reflects her dedication to improving healthcare outcomes but also underscores the importance of collaboration in research. By harnessing the potential of natural compounds, Gonzales continues to pave the way for new treatments in the challenging realm of brain injuries and strokes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…